日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer

抗 EGFR 抗体 JMT101 和奥希替尼治疗 EGFR 20 号外显子插入阳性非小细胞肺癌的 1b 期试验

Shen Zhao # ,Wu Zhuang # ,Baohui Han # ,Zhengbo Song # ,Wei Guo # ,Feng Luo # ,Lin Wu ,Yi Hu ,Huijuan Wang ,Xiaorong Dong ,Da Jiang ,Mingxia Wang ,Liyun Miao ,Qian Wang ,Junping Zhang ,Zhenming Fu ,Yihua Huang ,Chunwei Xu ,Longyu Hu ,Lei Li ,Rong Hu ,Yang Yang ,Mengke Li ,Xiugao Yang ,Li Zhang ,Yan Huang ,Wenfeng Fang

Coordination of tumor growth and host wasting by tumor-derived Upd3

肿瘤衍生的 Upd3 协调肿瘤生长和宿主消瘦

Guangming Ding, Xiaoxiang Xiang, Yanhui Hu, Gen Xiao, Yuchen Chen, Richard Binari, Aram Comjean, Jiaying Li, Elisabeth Rushworth, Zhenming Fu, Stephanie E Mohr, Norbert Perrimon, Wei Song

ZY3-02 Laser Altimeter Footprint Geolocation Prediction

ZY3-02激光高度计足迹定位预测

Xie, Junfeng; Tang, Xinming; Mo, Fan; Li, Guoyuan; Zhu, Guangbin; Wang, Zhenming; Fu, Xingke; Gao, Xiaoming; Dou, Xianhui

UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo

UBE2D3基因过表达增强食管癌细胞EC109体内外放射敏感性

Xiaojia Gao, Wenbo Wang, Hui Yang, Lin Wu, Zhongshi He, Shuliang Zhou, Hong Zhao, Zhenming Fu, Fuxiang Zhou, Yunfeng Zhou